NICE Impact Report Cardiovascular Disease Management

NICE Impact Report Cardiovascular Disease Management

NICE Recommends Dapagliflozin for Heart Failure

NICE Recommends Dapagliflozin for Heart Failure

NICE in the UK recommends Dapagliflozin (FORXIGA) to treat heart failure with reduced ejection fraction for patients with or without Diabetes.
Heart failure and Covid-19 Statement

Heart failure and Covid-19 Statement

Heart Failure Marvellous Award Winners 2021 for their outstanding contribution

Heart Failure Marvellous Award Winners 2021 for their outstanding contribution

Alice Fearn and Jai McDowall - Music Will Live in Our Hearts

Alice Fearn and Jai McDowall - Music Will Live in Our Hearts

World's First Self-Management Advent Calendar Launches

World's First Self-Management Advent Calendar Launches

European commission approves forxiga (dapagliflozin) for heart failure

European commission approves forxiga (dapagliflozin) for heart failure

Impact of COVID-19 and heart failure care in the UK

Impact of COVID-19 and heart failure care in the UK

Ways In Which To Support Heart Failure Foundations

Ways In Which To Support Heart Failure Foundations

Outlining The Best Ways To Prevent Heart Failure

Outlining The Best Ways To Prevent Heart Failure

Being There For A Loved One Who Is Diagnosed With Heart Failure

Being There For A Loved One Who Is Diagnosed With Heart Failure

How To Cope With a Heart Failure Diagnosis

How To Cope With a Heart Failure Diagnosis

A Breakdown Of The Various Types Of Heart Failure

A Breakdown Of The Various Types Of Heart Failure

COVID19, heart failure and the future

COVID19, heart failure and the future

Don't miss out

Sign up to our newsletter and get all the latest industry information on Events, Sales and Offers

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Donate